Antimicrobial Therapy 2022 (Pocket Edition)

Γίνε ο πρώτος που θα αξιολόγησει αυτό το προϊόν

Συγγραφείς:: David N. Gilbert , Henry F. Chambers

ISBN: 9781944272197

The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, The Sanford Guide to Antimicrobial Therapy provides information that is convenient, concise, and reliable.

€62,00

Ποσότητα:

+ -

What's new in 2022:

Numerous changes throughout, with major changes in the following areas:

New Drugs - Addition of new COVID-19 drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more.
New Tables - ECMO Drug Dosing Adjustment (Table 10F) and QTc Prolongation (Table 10G).
Table 1: Initial Choice of Antimicrobial Therapy - Numerous changes including 2021 CDC STI updates, recommendations for resistant infections.
Table 5: Recommendations for MDR Bacteria - Updates for gram-negative bacilli updated based on recent evidence and IDSA Guidelines.
Table 12: Treatment of Mycobacterial Infections - Revised recommendations for latent M. tuberculosis & non-tuberculous mycobacteria.
Table 13: Treatment of Parasitic Infections - Significant changes to amebic meningoencephalitis, babesiosis and trypanosomiasis, and updates to sources for antiparasitic drugs (Table 13D).
Table 14: Treatment of Viral Infections - Updates to COVID-19 treatment recommendations (digital subscriptions have most recent updates)

Περιγραφή
Λοιπά στοιχεία
Αξιολογήσεις
Ρωτήστε μας

What's new in 2022:

Numerous changes throughout, with major changes in the following areas:

New Drugs - Addition of new COVID-19 drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more.
New Tables - ECMO Drug Dosing Adjustment (Table 10F) and QTc Prolongation (Table 10G).
Table 1: Initial Choice of Antimicrobial Therapy - Numerous changes including 2021 CDC STI updates, recommendations for resistant infections.
Table 5: Recommendations for MDR Bacteria - Updates for gram-negative bacilli updated based on recent evidence and IDSA Guidelines.
Table 12: Treatment of Mycobacterial Infections - Revised recommendations for latent M. tuberculosis & non-tuberculous mycobacteria.
Table 13: Treatment of Parasitic Infections - Significant changes to amebic meningoencephalitis, babesiosis and trypanosomiasis, and updates to sources for antiparasitic drugs (Table 13D).
Table 14: Treatment of Viral Infections - Updates to COVID-19 treatment recommendations (digital subscriptions have most recent updates)

Προδιαγραφές προϊόντων

Εκδότες	The Sanford Guide
Εξώφυλλο	Μαλακό
Σελίδες	300
Έκδοση	52
Ημ. Έκδοσης	August 2022

Γράψτε τη δική σου αξιολόγηση

Μόνο οι εγγεγραμμένοι χρήστες μπορούν να γράψουν σχόλια

Τίτλος κριτικής:

Κείμενο κριτικής:

Βαθμολογία:

Κακή
Άριστη

Ονοματεπώνυμο

Το email σας

Μήνυμα

Προδιαγραφές προϊόντων

Εκδότες	The Sanford Guide
Εξώφυλλο	Μαλακό
Σελίδες	300
Έκδοση	52
Ημ. Έκδοσης	August 2022
ISBN	9781944272197

Ετικέτες προϊόντος

Antimicrobial Therapy 2022 (Pocket Edition)

Σχετικά με εμάς

Πληροφορίες

Ο λογαριασμός μου

Επικοινωνία